Ultrasis
Ultrasis
Ultrasis was a company that specialized in the development and delivery of computer-based healthcare solutions. The company was known for its innovative approach to mental health treatment, particularly through the use of technology to provide accessible and effective therapeutic interventions.
History
Ultrasis was founded in the late 20th century and quickly became a pioneer in the field of e-health. The company focused on creating software that could deliver cognitive behavioral therapy (CBT) and other psychological treatments via digital platforms. This approach aimed to make mental health care more accessible to individuals who might not otherwise seek traditional therapy.
One of Ultrasis's most notable products was "Beating the Blues," a computerized CBT program designed to help individuals manage depression and anxiety. This program was widely adopted by healthcare providers and was recognized for its effectiveness in clinical trials.
Products and Services
Ultrasis offered a range of products aimed at improving mental health and well-being. These included:
- Beating the Blues: A computerized CBT program for treating depression and anxiety.
- Living Life to the Full: An online course designed to help individuals develop skills to improve their mental health.
- GetFit Wellness: A program focused on promoting physical health and well-being through exercise and lifestyle changes.
The company's products were often used in conjunction with traditional therapy, providing a blended approach to treatment that could be tailored to individual needs.
Impact and Recognition
Ultrasis's work in the field of digital mental health was widely recognized. The company's programs were used by the National Health Service (NHS) in the United Kingdom, and "Beating the Blues" was one of the first computerized CBT programs to be recommended by the National Institute for Health and Care Excellence (NICE).
The company's innovative approach helped to pave the way for the broader acceptance and integration of digital solutions in mental health care.
Decline and Closure
Despite its early successes, Ultrasis faced financial difficulties in the 2010s. The company struggled to maintain profitability and eventually went into administration. The decline was attributed to various factors, including increased competition and challenges in scaling its business model.
Related Pages
References
<references group="" responsive="1"></references>
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian